Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB
about
Giant cell tumor of the temporal bone--a case reportGiant cell tumour of bone: morphological, biological and histogenetical aspectsThe clinical approach toward giant cell tumor of boneWnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceMolecular biology and therapeutics in musculoskeletal oncology.The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004).Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.Osteonecrosis of the jaw in a patient on Denosumab.Collagenase expression and activity in the stromal cells from giant cell tumour of bone.Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent.Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategyGiant cell tumour of bone: new treatments in development.Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.Rank ligand as a target in musculoskeletal neoplasms.Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.Histogenetic characterization of giant cell tumor of boneA case of thoracic giant cell tumor of bone and discussion of radiological features and current management practices.Retrospective analysis of patients with rare-site and metastatic giant cell tumor.Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation.Clinical applications of RANK-ligand inhibition.Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.Targeted therapies: the rare cancer paradigm.Therapeutic targeting of osteoclast function and pathways.The multidisciplinary management of giant cell tumor of bone.Giant cell tumor of bone: current treatment options.Giant cell tumor of bone: a neoplasm or a reactive condition?Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report.Overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in sacral giant cell tumors and the correlation with tumor microvessel densityA case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastasesGiant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone.Raloxifene can reduce giant cell tumor recurrence: a new adjuvant therapy.Identification of new genes associated to senescent and tumorigenic phenotypes in mesenchymal stem cells.Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis.In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.[Sarcoma gene signatures].
P2860
Q21256403-9836E6E3-281D-4B28-87F7-02B45545D2B6Q24595415-B32F6659-8F6F-4405-B855-2427DE538E38Q27024555-8B28E948-D454-4457-8422-FEBB57AE208DQ28312170-D078E544-522B-4968-9DB5-8CD88A7A9C18Q30426953-63F8E489-9333-4C44-A5B6-300D0AECAAFAQ33765607-C35B95A3-2715-4615-8784-A037D07E993EQ33840094-E32741AE-16C2-47BB-8488-ED0C1998C9E7Q33891868-13D23306-B053-43EB-9FDB-E5E059CDDF92Q33952332-1C864330-D49F-4138-8BAC-B6A962908847Q34417248-F7631D99-090E-4149-9EF2-8ADEFC85CD6AQ34902134-F925C32B-8F3D-4C3A-B2CC-1A2815B2E7C7Q35662668-4DFA6A8A-726F-4F02-ACAE-DA0605CF497FQ35935409-C909DFE9-86F8-4153-8DCF-91DDDB650D90Q35988028-56BA17E1-91F9-471E-BC35-58DCF5E802CCQ36240919-353AF505-56F0-4FD2-B8D3-64F865137294Q36364836-99D648E6-1747-48C1-825A-55A64B62C8A6Q36803589-5B0DA800-FE27-4305-82C1-383A1FAD1544Q37201651-FEEC8C75-B78E-405B-A82A-E07660396A2DQ37309465-21FA84FF-12B0-42AC-BEBB-3A1C6D770BAFQ37383985-046717EA-0847-451E-B27F-D4C884201989Q37438675-9EEFE91E-B5A2-4E63-AABF-4724BA459F4DQ37581613-9FBCF1C0-49A2-4291-9222-289258EFCCE1Q37632825-65ED3953-5110-4640-98AD-A7960512B97EQ37825905-3EA57EFD-61F4-46CC-9AD4-C66AC18F4309Q38199182-A8F3EE11-3B72-4324-B3CE-F20CCD347F08Q38208716-DE8E374F-6DB9-49D7-9382-804A480CD815Q40796975-78024574-FC4D-4DC1-888C-4E099FC808CDQ41061051-EBB8C351-DD94-4AA6-81BC-8220B0FBE3FCQ41769649-5BB60C55-78D7-4CF1-81D1-E533C12DAB11Q42410006-85948302-CC6C-4F95-906A-A74FB32269C9Q46004364-DC3AB66C-E3FD-4FF9-8A26-568905B0E9D1Q46296494-337217BF-CB3C-47AA-9ADC-56EB394D1BBCQ46515921-CB8A174B-CBF1-4AF4-924F-6BBB6666EFCAQ46834529-D891B40C-ABD8-4129-A6AE-EEAB25AA0747Q47126103-F6EDFE3F-1B41-4A89-B915-1214CF70B935Q49041245-E884762C-B347-4557-9336-8F7A6CF56E94Q49843242-EAAA2A68-CE52-4054-94FC-C3F55708AB4FQ51410603-868C355E-2267-4646-A690-974D4E58B386Q52891891-A1D066DB-FCA2-40C8-91FC-31D7A0824840Q54389752-C4B8D2CF-C624-4CBA-8295-7449B97FE540
P2860
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@ast
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@en
type
label
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@ast
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@en
prefLabel
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@ast
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@en
P2093
P2860
P1476
Molecular profiling of giant c ...... vator of nuclear factor kappaB
@en
P2093
Andrew J Holloway
David M Thomas
Gerald J Atkins
Gerald Powell
Ian Dickinson
John L Slavin
Maya Kansara
Melanie K Trivett
Paul Simmons
Peter F M Choong
P2860
P304
P356
10.1016/S0002-9440(10)62959-8
P407
P577
2005-07-01T00:00:00Z